{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003913","form_type":"8-K","ticker":"ANEB","cik":"0001815974","company_name":"Anebulo Pharmaceuticals, Inc.","filed_at":"2025-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.843389+00:00","generated_at":"2026-05-23T15:36:08.342221+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Anebulo shareholders approve authorized share increase to 75M and board declassification","bullets":["Stockholders approved raising authorized common shares from 50M to 75M at the April 4, 2025 Annual Meeting.","Certificates of amendment filed with Delaware on April 11, 2025.","Stockholders also approved declassification of the Board; all directors will stand for annual election starting next meeting.","Board adopted conforming Bylaws amendment effective upon the declassification charter amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003913","json":"https://secwatch.observer/filing/0001641172-25-003913.json","markdown":"https://secwatch.observer/filing/0001641172-25-003913.md","text":"https://secwatch.observer/filing/0001641172-25-003913.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815974/000164117225003913/0001641172-25-003913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815974/000164117225003913/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T15:36:08.342221+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}